Roche's Erivedge OK'd in Canada
08/27/2013
Erivedge (vismodegib) was recently approved in Canada for the treatment
of adult patients with histologically confirmed metastatic basal cell
carcinoma or locally advanced basal cell carcinoma inappropriate for
surgery or radiotherapy.